Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-

Background Methotrexate is an antimetabolite drug that blocks dihydrofolate reductase and impairs cellular DNA synthesis. Administration of intravenous iodinated radiocontrast agents can cause life-threatening toxicity in patients receiving methotrexate. Case A 60-year-old female patient with rheuma...

Full description

Bibliographic Details
Main Authors: Balaji Vaithialingam, Radhakrishnan Muthuchellappan, Mouleeswaran Sundaram
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2022-06-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kja-22067.pdf
_version_ 1818241768643100672
author Balaji Vaithialingam
Radhakrishnan Muthuchellappan
Mouleeswaran Sundaram
author_facet Balaji Vaithialingam
Radhakrishnan Muthuchellappan
Mouleeswaran Sundaram
author_sort Balaji Vaithialingam
collection DOAJ
description Background Methotrexate is an antimetabolite drug that blocks dihydrofolate reductase and impairs cellular DNA synthesis. Administration of intravenous iodinated radiocontrast agents can cause life-threatening toxicity in patients receiving methotrexate. Case A 60-year-old female patient with rheumatoid arthritis underwent a craniotomy and clipping of a distal anterior cerebral artery aneurysm. The patient had been on low-dose oral methotrexate for the previous 5 years, which was discontinued two days before surgery. The patient received the first intravenous contrast agent injection (iohexol) during diagnostic cerebral angiography one day prior to surgery (50 ml) and the second contrast dose on the first postoperative day (60 ml). The patient developed severe methotrexate toxicity, leading to fatal multiorgan failure and death following repeated contrast imaging with intravenous iohexol. Conclusions Even though low-dose oral methotrexate has minor adverse effects, life-threatening toxicity can be precipitated in the presence of iodinated contrast agents.
first_indexed 2024-12-12T13:34:35Z
format Article
id doaj.art-71df3e53ae964de8bb63dd4301bd5719
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-12T13:34:35Z
publishDate 2022-06-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-71df3e53ae964de8bb63dd4301bd57192022-12-22T00:23:00ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632022-06-0175328328510.4097/kja.220678797Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-Balaji VaithialingamRadhakrishnan Muthuchellappan0Mouleeswaran Sundaram1 Department of Neuroanesthesia and Neurocritical Care, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India Department of Neuroanesthesia and Neurocritical Care, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, IndiaBackground Methotrexate is an antimetabolite drug that blocks dihydrofolate reductase and impairs cellular DNA synthesis. Administration of intravenous iodinated radiocontrast agents can cause life-threatening toxicity in patients receiving methotrexate. Case A 60-year-old female patient with rheumatoid arthritis underwent a craniotomy and clipping of a distal anterior cerebral artery aneurysm. The patient had been on low-dose oral methotrexate for the previous 5 years, which was discontinued two days before surgery. The patient received the first intravenous contrast agent injection (iohexol) during diagnostic cerebral angiography one day prior to surgery (50 ml) and the second contrast dose on the first postoperative day (60 ml). The patient developed severe methotrexate toxicity, leading to fatal multiorgan failure and death following repeated contrast imaging with intravenous iohexol. Conclusions Even though low-dose oral methotrexate has minor adverse effects, life-threatening toxicity can be precipitated in the presence of iodinated contrast agents.http://ekja.org/upload/pdf/kja-22067.pdfanesthesiaiohexolleucovorinmethotrexaterheumatoid arthritistoxicity
spellingShingle Balaji Vaithialingam
Radhakrishnan Muthuchellappan
Mouleeswaran Sundaram
Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
Korean Journal of Anesthesiology
anesthesia
iohexol
leucovorin
methotrexate
rheumatoid arthritis
toxicity
title Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
title_full Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
title_fullStr Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
title_full_unstemmed Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
title_short Fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low-dose oral methotrexate -a case report-
title_sort fatal multiorgan dysfunction following repeated iodinated radiocontrast injection in a patient receiving low dose oral methotrexate a case report
topic anesthesia
iohexol
leucovorin
methotrexate
rheumatoid arthritis
toxicity
url http://ekja.org/upload/pdf/kja-22067.pdf
work_keys_str_mv AT balajivaithialingam fatalmultiorgandysfunctionfollowingrepeatediodinatedradiocontrastinjectioninapatientreceivinglowdoseoralmethotrexateacasereport
AT radhakrishnanmuthuchellappan fatalmultiorgandysfunctionfollowingrepeatediodinatedradiocontrastinjectioninapatientreceivinglowdoseoralmethotrexateacasereport
AT mouleeswaransundaram fatalmultiorgandysfunctionfollowingrepeatediodinatedradiocontrastinjectioninapatientreceivinglowdoseoralmethotrexateacasereport